Dare Bioscience Stock Technical Analysis

DARE Stock  USD 2.40  0.03  1.27%   
As of the 8th of July, Dare Bioscience shows the Mean Deviation of 1.63, variance of 6.0, and Standard Deviation of 2.45. Dare Bioscience technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Dare Bioscience information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Dare Bioscience is priced favorably, providing market reflects its regular price of 2.4 per share. Please also check Dare Bioscience jensen alpha, which is currently at (0.26) to verify the company can sustain itself at a future point.

Dare Bioscience Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Dare, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DareDare Bioscience's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Dare Bioscience Analyst Consensus

Target PriceAdvice# of Analysts
13.0Strong Buy4Odds
Dare Bioscience current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Dare analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Dare stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Dare Bioscience, talking to its executives and customers, or listening to Dare conference calls.
Dare Analyst Advice Details
Dare Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Dare Bioscience technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Dare Bioscience trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Dare Bioscience Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Dare Bioscience volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Dare Bioscience Trend Analysis

Use this graph to draw trend lines for Dare Bioscience. You can use it to identify possible trend reversals for Dare Bioscience as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Dare Bioscience price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Dare Bioscience Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Dare Bioscience applied against its price change over selected period. The best fit line has a slop of   0.0052  , which may suggest that Dare Bioscience market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1.02, which is the sum of squared deviations for the predicted Dare Bioscience price change compared to its average price change.

About Dare Bioscience Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Dare Bioscience on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Dare Bioscience based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Dare Bioscience price pattern first instead of the macroeconomic environment surrounding Dare Bioscience. By analyzing Dare Bioscience's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Dare Bioscience's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Dare Bioscience specific price patterns or momentum indicators. Please read more on our technical analysis page.

Dare Bioscience July 8, 2025 Technical Indicators

Most technical analysis of Dare help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Dare from various momentum indicators to cycle indicators. When you analyze Dare charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Dare Bioscience July 8, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Dare stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Dare Stock analysis

When running Dare Bioscience's price analysis, check to measure Dare Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dare Bioscience is operating at the current time. Most of Dare Bioscience's value examination focuses on studying past and present price action to predict the probability of Dare Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dare Bioscience's price. Additionally, you may evaluate how the addition of Dare Bioscience to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements